Literature DB >> 1326398

High frequency of human papillomavirus infection in carcinoma of the urinary bladder.

K Anwar1, H Naiki, K Nakakuki, M Inuzuka.   

Abstract

BACKGROUND AND METHODS: The prevalence of type 6, 11, 16, 18, and 33 human papillomavirus (HPV) was investigated with the polymerase chain reaction (PCR) on formalin-fixed, paraffin wax-embedded material, including 48 neoplastic and 21 normal urinary bladder specimens. The PCR-amplified DNA were analyzed by gel electrophoresis and dot blot and Southern blot hybridization. Some tissues were tested further by nonisotopic in situ hybridization.
RESULTS: HPV DNA was detected in 39 (81%) of 48 carcinomas and 7 (33%) of 21 normal urinary bladder specimens. The presence of high-risk HPV (types 16, 18, and 33) was increased significantly in carcinoma cases (62%) as compared with normal specimens (14%) (P less than 0.01). Similarly, multiple HPV infections were significantly higher in carcinoma (60%) than in the normal tissues (5%) (P less than 0.01). The overall and high-risk HPV infections in both neoplastic and normal specimens were distributed almost equally in male and female patients. There was no significant correlation between positive results for HPV and histologic grades of the carcinoma.
CONCLUSIONS: These results demonstrate that the urinary bladder in both sexes is another site where infection with the common genital tract HPV may carry a risk of malignant transformation.

Entities:  

Mesh:

Year:  1992        PMID: 1326398     DOI: 10.1002/1097-0142(19921001)70:7<1967::aid-cncr2820700726>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Human papillomavirus infection and bladder cancer risk: a meta-analysis.

Authors:  Ni Li; Lin Yang; Yawei Zhang; Ping Zhao; Tongzhang Zheng; Min Dai
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

Review 3.  Human papillomavirus and bladder cancer.

Authors:  N R Boucher; J B Anderson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

4.  Human papillomavirus and schistosomiasis associated bladder cancer.

Authors:  K Cooper; Z Haffajee; L Taylor
Journal:  Mol Pathol       Date:  1997-06

5.  Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors.

Authors:  Thanaa El A Helal; Mona T Fadel; Naglaa K El-Sayed
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

6.  Histological features of human papilloma virus 16 and its association with the development and progression of anal squamous cell carcinoma.

Authors:  Ryuzaburo Kagawa; Tetsuya Yamaguchi; Reiko Furuta
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

7.  Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid.

Authors:  N Hayashi; M Furihata; Y Ohtsuki; H Ueno
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Transitional cell papilloma of the penis associated with human papilloma virus infection. Report of two cases.

Authors:  Socorro María Rodríguez-Pinilla; José Luis Rodríguez-Peralto; María Teresa Férnandez-Figueras
Journal:  Virchows Arch       Date:  2003-05-01       Impact factor: 4.064

9.  Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients.

Authors:  Hala Badawi; Hanem Ahmed; Ahmed Ismail; Manal Diab; Magd Moubarak; Afkar Badawy; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-10-08

10.  Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature review.

Authors:  Sergei Guma; Remegio Maglantay; Ryan Lau; Rosemary Wieczorek; Jonathan Melamed; Fang-Ming Deng; Ming Zhou; Danil Makarov; Peng Lee; Matthew R Pincus; Zhi-Heng Pei
Journal:  Am J Clin Exp Urol       Date:  2016-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.